Cell and gene therapies are advancing into late-stage development and commercialization, where raw materials have become a critical determinant of whether programs succeed or fail. Small inconsistencies that once went […]

The 14th IMPACCT Real-World Evidence Summit is the only dedicated industry forum uniting leaders across RWE, real-world data, evidence generation, HEOR, and market access to tackle the most pressing challenges […]

GLP-1s changed the treatment paradigm for obesity reaching new heights of efficacy. Now, as unmet need persists and the field looks beyond efficacy alone, momentum is building behind therapies that […]

10th Dermatology Drug Development Summit – Discovering, Developing & Commercializing Next-Generation Inflammatory Skin Disease Therapeutics - November 3-5, 2026 | Boston, MA The 10th Dermatology Drug Development Summit returns in […]

The 9th RNA-Targeted Drug Discovery & Development Summit returns to Boston, MA, on November 10–12, 2026, as the industry's only dedicated meeting focused exclusively on RNA-targeted small molecules, bringing together leading minds from biotech, […]

The 9th Lab Asset & Facility Management (LAFM) Summit 2026 is the leading industry forum dedicated to helping pharmaceutical and biotech organizations optimize lab operations, asset management, facilities, engineering, and […]

South Korea’s cell and gene therapy landscape is highly dynamic, as observed from regulatory approvals, clinical trial progress, and manufacturing activity, from over 150 companies in active drug development. Additionally, […]

Driven by South Korea’s government making strategic investments in mRNA platforms and growing collaboration between global pharma and local biotech innovators, the field is experiencing renewed development momentum. This is […]

Hot off the press: The biomarker operations and biospecimen community finally has its own dedicated forum. Introducing the inaugural Biomarker Operations & Biospecimen Management Summit, the industry's first, purpose-built meeting […]

As model-informed drug development (MIDD) becomes increasingly central to modern drug development strategy, organizations are under growing pressure to leverage quantitative approaches that accelerate timelines, reduce risk, and improve regulatory […]

Introducing Europe’s first CNS Biomarker Forum. The Novel CNS Biomarkers Summit Europe is the only European meeting dedicated exclusively to advancing fluid, imaging, and digital biomarkers for CNS drug development. Bringing […]

The 8th CNS Drug Delivery Summit is the leading industry forum dedicated to overcoming the challenges of delivering therapeutics across the blood-brain barrier and into the central nervous system. Bringing […]

The World CNS Summit South Korea is the premier industry-focused forum dedicated to advancing targeted, mechanism-differentiated therapies for neurodegenerative, rare neurodevelopmental, and neuropsychiatric disorders. As South Korea emerges as a […]

The 10th Complement-Based Drug Development Summit returns at a pivotal moment as the field shifts from validating complement biology to maximizing its clinical and commercial potential. As pipelines expand beyond […]